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Infectious marine diseases can decimate populations and are increasing
among some taxa due to global change and our increasing reliance on
marine environments. Marine diseases become emergencies when significant
ecological, economic or social impacts occur. We can prepare for and manage
these emergencies through improved surveillance, and the development and
iterative refinement of approaches tomitigate disease and its impacts. Improv-
ing surveillance requires fast, accurate diagnoses, forecasting disease risk and
real-time monitoring of disease-promoting environmental conditions. Diver-
sifying impact mitigation involves increasing host resilience to disease,
reducing pathogen abundance and managing environmental factors that
facilitate disease. Disease surveillance and mitigation can be adaptive if
informed by research advances and catalysed by communication among
observers, researchers and decision-makers using information-sharing plat-
forms. Recent increases in the awareness of the threats posed by marine
diseases may lead to policy frameworks that facilitate the responses andman-
agement that marine disease emergencies require.
1. Introduction
Frequent and severe disease outbreaks are hypothesized to be a consequence of
cumulative natural and anthropogenic stressors and could affect many marine
species [1–3]. Most recently, a wasting disease outbreak decimated populations
of sea stars (Asteroidea) in intertidal and sub-tidal regions of eastern and western
North America [4]. In addition to uncounted deaths in the east, millions of indi-
viduals died in California, Oregon and Washington in 2013 and 2014 and more
are dying now in Alaska [5]. The high mortality rate, unprecedented geographi-
cal scope and multi-species scale of impacts caught the scientific and resource
ecological economic social
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Figure 1. Marine diseases classifiable as emergencies due to the scope and scale of ecological, economic and social impacts. (a) Sea star wasting disease,
(b) eelgrass wasting disease, (c) shrimp white spot disease, (d ) white plague disease in the Caribbean coral Dendrogyra cylindrus, (e) Vibrio parahaemolyticus
and V. vulnificus infections in oysters and ( f ) epizootic shell disease in lobsters. Most of these as well as many other marine disease emergencies cause significant
impacts in more than one category. (Online version in colour.)
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2management community by surprise, emphasizing that we
lack an effective framework for the detection and manage-
ment of marine diseases.
The recent experience with the sea star wasting disease
(SSWD) outbreak suggests early detection and diagnosis
is the key to response and management. Fortunately, as
reports of marine disease impacts are increasing, so is interest
in creating policy to manage marine diseases. Such
policy needs to address several basic questions including:
(i) which marine disease outbreaks warrant management
responses? And, (ii) how can we prepare for and manage
marine disease emergencies? To answer these questions, we
describe how coordinated research and management of
marine diseases can reduce disease and its impacts for a var-
iety of marine organisms. We provide examples of ongoing
marine disease surveillance and response and discuss some
of the inconsistencies in the coordination of these efforts. In
the USA and Canada, governmental, non-profit and aca-
demic agencies often coordinate management responses.
However, many recent marine disease outbreaks constitute
emergencies not covered under current policies. Managing
emerging outbreaks is essential and viable with strategic
investment in research and response.2. Which marine disease outbreaks are
emergencies that warrant management
responses?
Every disease is not an emergency. Parasites and pathogens
are common in seaweeds and fishes. The typical fish caught
by any marine angler often contains several parasite species,
yet may still appear healthy. Most infectious agents do notcause noticeable disease and, even when they do, the result-
ing population impacts may be beneficial to the marine
community by returning host abundances to carrying
capacity [6]. Even mass mortalities may not constitute an
emergency if the die-off is localized, the outbreak is self-limit-
ing, the system is resilient to the loss of the host, the species’
existence is not under other threats, or the infectious agent
does not put human communities at risk. However, when a
disease causes large declines in the host population resulting
in endangerment of that taxa or precipitating lasting ecologi-
cal, economic or social impacts (figure 1), it becomes an
emergency [2,3,7].
We define marine diseases as emergencies for their dis-
ruption of ecosystem functioning if they remove keystone
predators or foundational species. For instance, the recent
SSWD outbreak described in the introduction remains an
emergency (figure 1a). Resultant ecological impacts are still
unfolding and include a reduction in long-term ecological
integrity through shifts in populations of foundation species
such as mussels and ecosystem engineers like sea urchins.
Seagrass wasting disease is a historical example (figure 1b)
[8]. In the 1930s, a seagrass wasting disease epidemic in the
North Atlantic extirpated an entire coastal ecosystem that
had provided food for migratory birds and valuable habitat
for commercially important fish and shellfish [9]. A range
of ecosystem services deteriorated as a result, including sedi-
ment retention, filtration of waste nutrients and carbon
sequestration [8,10]. While some ecological effects may be
expected from most marine diseases, they are of higher con-
cern when they reduce ecosystem services, biodiversity or
ecosystem-level resilience to additional stresses.
The most costly epidemics are those affecting commercial
species. The annual global value of wild and farmed fisheries
is estimated in the 100s of billions of US dollars [11]. At least
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367 infectious diseases have been identified as negatively
impacting the economy of marine-based industries [12]. For
example, billions of dollars were lost in the early 1990s as a
result of a global pandemic of white spot syndrome in
penaeid shrimp [12] (figure 1c). The pandemic was exacer-
bated by the high susceptibility of hosts to this viral
pathogen and the movement of infected product among
farms [12]. Subsequent management and mitigation of
white spot has resulted in a return to profitable shrimp farm-
ing [13]. Economic losses associated with reduced ecotourism
following disease outbreaks can also be substantial. Coral dis-
eases have led to widespread mass mortality of acroporid
corals throughout their geographical distribution [14]. In
the early 1980s, white band disease changed the structure
and composition of Caribbean coral reefs and affected reef-
dependent fisheries and tourism industries (figure 1d ) [14].
These examples demonstrate that marine diseases can cause
emergencies if the economic costs are substantial.
Marine disease emergencies can also have significant
social impacts capable of disrupting public safety, threaten-
ing human health or decreasing the resilience of local
human communities. Along with our reliance on ocean
resources, the probability of humans acquiring infections
from marine organisms is also increasing [15]. These
include brucellosis, leptospirosis and trichinellosis from
marine mammals, avian influenza from marine birds and
cryptosporidiosis and vibriosis from shellfish [16]. The
most common infection route is ingestion through seafood,
such as oysters. For example, transmission of pathogenic
Vibrio parahaemolyticus and V. vulnificus through shellfish
or other means can cause human gastrointestinal illness,
septicaemia, cellulitis and, in some cases, death (figure 1e)
[17]. Both V. parahaemolyticus and the more lethal V. vulnifi-
cus have increased recently as a direct response to ocean
warming [18]. The emergence of epizootic shell disease in
lobsters also demonstrates how marine diseases can
impact human communities. Shell disease has severely
damaged the historic southern New England stock, redu-
cing an important resource for lobster fishermen in Long
Island Sound and Cape Cod [19,20]. In turn, these losses
have downstream impacts on the livelihood and economic
vitality of these fishing communities. Collectively, these
examples demonstrate how disease outbreaks that constitute
emergencies can have ecological, economic and social
impacts.3. How can we systematically prepare for and
manage marine disease emergencies?
Preparing for and managing marine diseases requires sur-
veillance and responsive mitigation (figure 2). Filling key
information and capacity gaps through research, outreach
and education informs management programmes for dis-
ease surveillance and mitigation. Consequently, the process
used to prepare for and manage a disease emergency is
adaptive; one refines diagnostic methods, initiates surveil-
lance programmes and tailors impact mitigation as
research advances and capacity among the community
builds (figure 2). The response framework we recommend
below highlights how effective disease surveillance creates
opportunities to proactively mitigate disease and its
impacts.(a) Pathogen and disease surveillance: the key to
proactive impact mitigation
Disease surveillance requires the use of fast and accurate
diagnostic tools to identify causative agents within clinically
unhealthy individuals or to determine the presence of certain
pathogens in a host or environment. Some governmental,
non-profit and academic organizations do on-going marine
disease surveillance for numerous diseases (electronic sup-
plementary material, table S1). Federal agencies such as the
National Oceanic and Atmospheric Administration and the
National Institutes of Health monitor diseases of marine
mammals in the USA, universities and state agencies monitor
diseases in many crustaceans and shellfish in the USA and
Canada, and a variety of organizations including academic
institutions, international non-governmental organizations
and federal and state agencies monitor diseases of corals
around the globe. Diagnostic tools are critical for early detec-
tion in the absence of visible or clinical signs or when the
causative agent is unknown or multifactorial (e.g. dual infec-
tions or a combination of infection and temperature). Such
tools have to be paired with strategic spatio-temporal
sampling designed to detect new or emerging pathogens
close to their onset. This risk-based surveillance is impor-
tant because knowledge gaps in how infectious agents
propagate and disperse in the ocean constrain predictive
modelling. Nonetheless, when possible, data-driven fore-
casting of disease-promoting conditions or modelling of
disease dynamics can inform sampling programmes. This
can result in the application of mitigation strategies before,
or at the onset of an outbreak. Delaying diagnoses will be
likely to make the problem more difficult to manage.
Fortunately, new diagnostic techniques are under devel-
opment [21]. Recent advances in diagnostic tools such as
quantitative PCR, flow cytometry and immunocapture tech-
niques improve the ability to quantify specific pathogens at
low cost. For example, in a single run with the commercially
available platform Fluidigm BioMarkw, it is possible to sim-
ultaneously perform 96 unique diagnostic tests on 96 samples
while maintaining high analytical sensitivity [22]. The
Department of Fisheries and Oceans Canada is using this
platform to monitor wild and farmed salmonids for a multi-
tude of infections [23]. In total, 47 assays for 46 microbes
suspected or known to cause disease worldwide, including
four viruses that are listed by the World Organisation for
Animal Health (OIE), are in development for simultaneous
assessment using this platform [23,24]. The utility of such
diagnostic tools will continue to improve as we focus on
their application to marine disease.
Although powerful, diagnostic methods have their limit-
ations [25]. For example, qPCR recognizes and quantifies
DNA of the target species (assuming high specificity of the
assay), but does not imply viability or infection [26]. These
assays, when fully validated, can be used as proxies for parasite
or disease presence, especially in locations where the disease
(agent) has been confirmed. Validation of diagnostic tools is a
critical, non-trivial step. The OIE Manual of Diagnostic Tests
for Aquatic Animals describes assay validation as a four-stage
pathway to assess a test’s ‘fitness-for-purpose’ (e.g. screening
versus confirmatory assay) in a designated target population/
species: stage 1, analytical characteristics; stage 2, diagnostic
sensitivity and specificity; stage 3, reproducibility among lab-
oratories; and stage 4, programme implementation [24].
disease classified as emergency?
?
surveillance
mitigating disease impacts
mitigating
downstream impacts
research communication
surveillance: develop and trial diagnostic
tools, model transmission processes,
evaluate zoonotic potential, quantify shifts
in host–pathogen–environment
relationships
management: examine effectiveness of
management actions, ensure vulnerability
assessments include disease
routine tasks responsive tasks
host: chemotherapeutics, vaccines,
culling, selective breeding
ecology: maintain ecosystem function
and supporting resilience
economy: regulate screening and
biosecurity
social: raise awareness and supporting
adaptive capacity
researchers: disseminate findings of
surveillance, forecasts and new research
researchers and managers: coordinate
responses, trial mitigation approaches
sci/Mgmt community and stakeholders:
raise awareness, develop partnerships via
information exchange and citizen science
monitoring programs
pathogen: direct removal, phage
therapy, biosecurity practices
environment: pollution control,
watershed management, marine
protected areas
accurate diagnostics: necropsy,
bio-imaging and molecular techniques
risk-based sampling: sentinel species
and environmental conditions
data-driven forecasting and
predictive modelling: seasonal
forecasts and real-time assessment
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Figure 2. A framework for adaptively managing marine disease emergencies. Routine disease surveillance enables early detection of more diseases. A working group
then determines whether the disease is an emergency, triggering responsive efforts to mitigate disease and downstream impacts. Surveillance tools and mitigation
approaches are informed by research and catalysed by effective communication among researchers, managers and stakeholders. (Online version in colour.)
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4Completion of stages 1, 2 and 3 is interpreted as being fit for the
originally intended purpose, usually at a national level, and
would be expected for tests used in a diagnostic laboratory set-
ting.Without validation, interpretation of diagnostic test results
becomes challengingwith unknown false positive and negative
rates. Development of validated diagnostic tools for pathogens
in non-commercial species, such as seastars, sea urchins and
many species of crabs or lobsters, is needed and may shed
light on the ecological role of the pathogen, whether it is obli-
gate, facultative or opportunist, a generalist or a specialist, and
if it is newly introduced to an area.
The advantages of rapid diagnostic tools are only realized
with strategic spatio-temporal sampling, which can be
informed through identification of risk factors using epide-
miological models, risk analysis and disease simulations.
Risk factors can relate to the host (e.g. species, demographic
stage and sex), pathogen (e.g. range expansions or changes in
virulence) or environment (e.g. temperature or salinity).
Filter-feeding shellfish that act as bioaggregators of microbes
in the water column can help monitor for the presence of
human pathogens. For instance, mussels in the northeast
coast of the USA have the highest disease prevalence and
parasite burdens in the USA mussel watch programme,
suggesting that this may be an area to target future surveil-
lance [27]. Similarly, marine mammals are monitored as
sentinel species for zoonotic pathogens, due to their phyloge-
netic and dietary similarity to humans, long-life and high-
level of exposure to pathogens [16]. In both cases, diagnostic
tools and strategic sampling have been paired to detect and
respond to diseases as well as understand their ultimate
causes (figure 3).
For some diseases affecting tropical corals, web-accessible
seasonal forecasts and near real-time assessments of outbreaklikelihoods exist. White syndrome outbreaks in Australia’s
Great Barrier Reef occurred with greater severity following
mild winters and when summer conditions were warm
[28,29]. These empirical findings were made possible by stra-
tegic monitoring programmes that assessed disease presence
and severity for 10 years. The forecasting tools developed
from such observations can visualize outbreak likelihoods
as high, medium or low based on data-driven mathematical
algorithms that query remotely sensed sea surface tempera-
ture datasets (figure 4). Assessments showing high
outbreak likelihoods trigger managers to target monitoring
efforts and, if disease is severe, implement actions to reduce
impacts or support recovery. Essentially, forecasting dis-
ease-promoting conditions increases support for and the
vigilance of those engaged in disease surveillance, which
can result in earlier and more robust disease detection.
Forecasting tools can be developed for other diseases if
two criteria are met: (i) the major environmental risk factors
for disease are known; and (ii) the relevant environmental
data are available regularly and at a sufficiently high quality
and spatial and temporal resolutions to represent conditions
the organisms experience [30]. Candidate diseases for the
development of forecasting tools include seagrass wasting
disease and abalone withering syndrome because field and
experimental data exist to calibrate and validate models.
Recent advances allow such forecasts and real-time assess-
ments of environmental conditions to be paired with
models of disease transmission and spread. For example,
three-dimensional oceanographic models that enable hydro-
dynamic modelling of environmentally sensitive pathogens
has proved useful for predicting transmission probabili-
ties of salmon pathogens, thereby influencing aquaculture
strategies in Norway [31]. Monitoring of environmental
400x
(b)(a)
Figure 3. Cetacean morbillivirus (CeMV) causes dolphin stranding and mortality. Identifying CeMV as the cause of a mortality event depends on: fresh tissues,
trained responders (a), and available, equipped diagnostic laboratories. In 2013/2014 CeMV was detected by PCR, virus isolation and histology, which stains intensely
brown where the virus is present (b). This rapid response effort was made possible under the US Marine Mammal Health and Stranding Program. Under future
legislation, similar coordinated responses could be possible for diseases in other marine taxa. Photos courtesy of Virginia Aquarium & Marine Science Center (both)
and David Rotstein (b). (Online version in colour.)
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5conditions conducive to marine disease outbreaks will be
increasingly important as the climate changes. As with diag-
nostics and sampling, developing data-driven forecasting
tools and predictive modelling for marine diseases will
require new investments in research that could be facilitated
by policy changes.
(b) Shifting host–pathogen–environment
relationships to mitigate disease
Management interventions can reduce the extent or severity
of the outbreak itself, dispelling the notion among some
that nothing can be done to reduce marine diseases [12]. Miti-
gation options include targeting the host or the infectious
agent, ameliorating disease-promoting environmental con-
ditions, or some combination (figure 5). The majority of
mitigation efforts undertaken to date have been for diseases
related to aquaculture and for marine mammals in wildlife
hospitals. Nonetheless, there are some examples of disease
mitigation in wild populations (table 1). These programmes
often target the host by reducing the pool of infectious or sus-
ceptible individuals. This includes vaccination (e.g. on fish
farms [39] or, for marine mammals [40]), application of
chemical treatments to lower pathogen intensity [39], culling
of diseased individuals or even whole populations (e.g. sabel-
lid worms in abalone and various pathogens in farmed
salmon [12]), and proper disposal of sick individuals that
incorporates biosecurity measurements (e.g. crabs with
bitter crab syndrome, bycatch or offal from processing
plants) [41,42]. Host populations can also be manipulated
by promoting increased resistance to disease. Frequencies of
resistant genotypes may be increased in wild populations
through the designation of marine protected areas (MPAs)
or sanctuaries, or in aquaculture populations through selec-
tive breeding. Both of these methods are being used to
increase resistance in oysters affected by MSX and dermo dis-
eases [33]. Managers are not forced to watch in despair as a
marine disease emergency unfolds.Interventions that directly target marine pathogens are
effective by either direct removal of pathogens or manipu-
lation of microbial communities to reduce pathogen
virulence. Methods for direct removal of sea lice on salmon
farms include biological control by co-stocking with endemic
cleaner fish that are sea louse predators [43]. In another
approach, mussels (Mytilus edilus) are placed near salmon
farms to filter larval sea lice and pathogenic Vibrio bacteria
species from the water column [44,45]. These multi-trophic
approaches are promising for sustainable management of
various types of infections in aquaculture and warrant con-
tinued development. Phage therapy also has potential. In
this approach, pathogenic bacteria are targeted with specific
viruses that lyse the cells [46] or, in the case of the rickett-
sia-like organisms that cause withering syndrome in
abalone, reduce the virulence of the infected cells [47]. Inter-
ventions like these require creative problem-solving based on
research.
Altering the environmental conditions where marine dis-
eases occur can also be effective at reducing impacts. Many
natural marine habitats provide ecosystem services in the
form of disease reduction. For example, shrimp aquaculture
benefits from nearby mangrove forests, through filtering of
water-borne pollutants and supply of larval broodstock
[48]. Mangroves restoration could improve water quality
and reduce nutrients that trigger disease and reduce the
need to import shrimp larvae (which might introduce dis-
ease). Similarly, because seagrasses have been shown to
filter and detoxify human pathogens and other pollutants
[8,49], protecting or restoring seagrasses that harbour valu-
able bacteria with algicidal properties against harmful algal
blooms could have beneficial effects [50]. While environ-
mental manipulations are most feasible on smaller scales,
such as those relevant to aquaculture, they can also occur at
larger scales. For example, Vibrio sp. are known to increase
with nutrient-driven increases in estuarine plankton [51].
Watershed-based reductions of nutrient loading to estuarine
systems can retain the natural abundance and diversity of
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Figure 4. Predictive tools developed for the coral disease white syndromes (WS) in Australia’s Great Barrier Reef. Statistical analyses were used to relate sea surface
temperature patterns in the winter (seasonal forecast (a)) and summer (near real-time risk assessment (b,c)) to WS prevalence during outbreak and non-outbreak
years [28,29]. These web-accessible tools are monitored by managers and scientists and used to target response efforts. Forecasting and near real-time monitoring of
disease-promoting conditions can increase vigilance and support for surveillance efforts, resulting in earlier disease detection. (Online version in colour.)
host pathogen environment
(b)(a) (c)
Figure 5. Management of oysters in the eastern US to reduce the impacts of Perkinsus marinus (dermo) and Haplosporidium nelsoni (MSX) can target the host, the
pathogen or the environment. Disease-resistant hosts are protected in sanctuaries from harvest to promote an increase in the frequency of resistant genotypes (a).
Biosecurity management focuses on pathogen screening in aquacultured seed (viewed histologically here) to prevent disease introduction into new areas and exacer-
bation of disease where it occurs (b). Conserving and restoring three-dimensional reef habitat enhances growth, reproduction and recruitment of healthy oyster
metapopulations (c). (Online version in colour.)
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6bacterial and phytoplankton species in the receiving waters,
thereby reducing risks to human health [52]. Another effec-
tive strategy is to reduce the impacts of other stressors on
diseased species. For example, designation of MPAs can
decrease the amount of damage resulting from boats, aban-
doned fishing gear and human impacts [53]. Such areas
have lower coral disease prevalence than adjacent areas that
are frequently visited and fished [54].(c) Mitigating downstream impacts of marine diseases
Mitigating marine disease itself reduces downstream ecologi-
cal, economic and social impacts; however, in many cases the
impacts themselves require mitigation. The local context and
constraints, including whether the affected populations and
communities can benefit from changes in human activities
or habitat restoration, will dictate what types of restoration
are possible. A recent meta-analysis suggests that, while
often slow, restoration of impacted ecosystems can be suc-
cessful [55]. These actions may help to mitigate economic
and social impacts, though there are also more direct options.Direct mitigation of economic impacts of diseases can
include revising stock-recruitment fishery models to expli-
citly account for disease [56] and ensuring biosecurity
practices reduce or eliminate transport of infected individuals
and product. Both the Pacific herring and Tanner crab indus-
tries have used stock assessment models that include disease
and adjust allowable catch to account for disease-induced
mortality [32,38]. Changes to those fisheries models were
implemented after disease outbreaks occurred, but such
model adjustments can be made more proactively in the
future for other marine diseases through increased monitor-
ing of risk factors.
The billions of dollars lost due towhite spot disease among
panaeid shrimp in the 1990s demonstrates the role that biose-
curity practices play in reducing economic impacts (figure 1c).
Biosecurity is also critically important for reducing the most
alarming of social impacts: human illness and death. Concerns
about spillover of marine diseases into humans usually
involve food or water-borne contact. Such contact can often
be reduced through public health messaging. For example,
when a V. parahaemolyticus outbreak occurs in a particular
Table 1. Marine disease mitigation in wild North American populations. Included are the disease mitigated, host and pathogen species, the agencies that have
conducted the mitigation, the strategies implemented and the project goal.
disease host pathogen mitigation approach agencya goal
bitter crab disease snow crabs Hematodinium sp. dispose of infected animals in
landfills; no culling of
diseased animals at sea [19]
DFO control
bitter crab disease Tanner crab Hematodinium sp. include disease in fisheries
models [32]
NOAA control
epizootic shell
disease
American
lobster
bacterial dysbiosis moratorium on being considered
on mid-Atlantic fishery [20]
ASMFC recovery
MSX, dermo oysters Haplosporidium
nelsoni, Perkinsus
marinus
promotion of resistant
populations through
sanctuaries from harvest,
rotational harvest programs
[33,34]
VMRC, MDNR recovery
sabellid infestation abalone,
black
turban
snails
sabellid polychaete
Terebrassabella
heterouncinata
culling of highly susceptible and
preferred hosts (black turban
snails), installing screens
at abalone mariculture
facility [35]
CDFG eradication
black band disease 12 coral
species
bacterial colonies vacuuming bacterial mat from
affected area and then sealing
with underwater epoxy [36]
NOAA,
universities
control disease
disease outbreak corals various close the reef to any human
activities [36]
NOAA prevent
transmission
viral haemorrhagic
septicaemia
(VHS)
salmonids viral haemorrhagic
septicaemia virus
(VHSv)
quarantine and cull hatchery
salmon testing positive [37]
WDFW control
icthyophoniasis, VHS Pacific
herring
Ichthophonus hoferi,
VHSv
include disease in fisheries
models [38]
NOAA control
aWDFW, Washington Department of Fish and Game; CDFG, California Department of Fish and Game; DFO, Department of Fisheries and Oceans Canada; ASMFC,
Atlantic States Marine Fisheries Commission; VMRC, Virginia Marine Resources Commission; MDNR, Maryland Department of Natural Resources.
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7area, the Interstate Shellfish Sanitation Conference requires the
Shellfish Control Authority to immediately close the affected
area, issue an advisory and initiate a recall of oyster and
other shellfish products [57]. These examples can be tailored
for use with other marine diseases.
Disease management must be adaptive and involve
information exchange. Importantly, timely implementation
and trial of mitigation actions hinges entirely on disease
surveillance. For some types of marine disease management
decisions, competing interests will have to be balanced and
many groups will need to be involved. Resolving contentious
issues that may involve public health or industry viability
will require clear policy and coordinated efforts. This attests
to the value of future policy for bringing increased attention
and resource mobilization to marine disease responses.4. Future directions and conclusion
Some marine disease outbreaks that qualify as emergencies are
ongoing (e.g. sea star wasting in Alaska and morbillivirus indolphins along the eastern seaboard of the USA) and new out-
breaks are certain to occur in the coming years. The framework
we used to summarize marine disease management can maxi-
mize opportunities to mitigate the impacts of future disease
emergencies. For the frameworkwe recommend to be adaptive,
both surveillance and responsive impact mitigation need to be
informedby research and catalysed byeffective communication
among research, management and stakeholder groups. Key
areas for investment of research effort include as follows.(a) Surveillance
— Developing and evaluating more diagnostic tools and
increasing capacity among the science and management
communities to use these tools.
— Developing hydrodynamic models of pathogen propa-
gation and dispersal.
— Quantifying the nature of shifts in host, pathogen
and environment relationships under climate and
anthropogenic change and using these data to develop
monitoring and forecasting tools.
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(b) management with disease surveillance programme
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Figure 6. How the proposed disease management framework improves the timing of disease detection and extent of impact mitigation. Currently, marine diseases
are detected near or after their epidemic peak (a) and there is limited management of the disease outbreak or downstream ecological, economic or social and
cultural impact. Diseases could be detected earlier with greater disease surveillance, which increases management opportunities, especially for mitigating down-
stream impacts (b). Diseases are best managed when surveillance programmes can include data-driven forecasting and predictive modelling, ensuring mitigation
starts before the epidemic peak (c) (see also figure 4). (Online version in colour.)
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8— Developing data-sharing and disease-mapping tools to
transfer information among scientists, managers and the
public.
(b) Impact mitigation
— Trialling and evaluating management actions implemented
to mitigate disease and its downstream impacts.
— Supporting the adaptive capacity of human communities
dependent on fisheries.
— Ensuring that vulnerability assessments of fisheries
include disease.
— Developing models and monitoring programmes to
assess disease impacts and mitigation plans.
(c) Development of marine disease adaptive
management policies
How might changes to policy help us diagnose and manage
marine diseases? One limitation is the lack of a coordinated
response or timely funding. For instance, investigation ofthe sea star wasting disease depended on interested parties
donating time and resources. The need for policy that
supports marine disease emergency responses and manage-
ment is starting to be recognized by some governing
bodies. In response to the ongoing SSWD outbreak, Washing-
ton state representative Dennis Heck of the US Congress
introduced a bill that, if passed, will become the Marine Dis-
ease Emergency Act (MDE Act, HR936). This bill would
increase capacity for timely and coordinated responses to
future marine disease outbreaks and would: (i) ensure
marine disease outbreaks are considered for classification as
‘emergencies’; (ii) appoint a working group in the US
National Oceanic and Atmospheric Administration to
advise on assessing, declaring and responding to emergen-
cies; (iii) form a data repository to disseminate and facilitate
research to manage disease impacts; and (iv) designate finan-
cial resources for research and response coordination.
A similar programme, the US Unusual Mortality Event
(UME) programme, coordinates responses to marine
mammal mortality events. After unprecedented mortalities
of dolphins along the eastern seaboard of the USA in 1987
and 1988 [58], this programme was established under the
Marine Mammal Protection Act (MMPA) amendments in
rstb.royalsocietypublishing.org
Phil.Trans.R.Soc.B
371:2
91992. The value of the MMPA for marine mammals was
demonstrated during the rapid response to increasing dol-
phin mortalities following the Deepwater Horizon oil spill
in the Gulf of Mexico [59]. However, the MMPA does not
cover either fish or invertebrates, hence the need for the pro-
posed MDE Act.
Disseminating surveillance data and research findings
through open access data repositories will facilitate research
and uptake of findings among decision-makers. The recent
proliferation of information-sharing platforms is a positive
part of this era of rapid change within which we have to
manage marine disease. Indeed, linked open data that
enables sophisticated data queries is already revolutionizing
human disease diagnosis and care management (e.g. [60]).
Such communication platforms can connect marine disease
researchers with decision-makers. Consequently, manage-
ment and responses coordinated under the MDE Act or
future similar legislation can be adaptive and effective
(figure 6). Research advances can be incorporated intomanagement strategy and responses can be coordinated
when disease is detected or anticipated, warranting these
marine emergencies the attention they require.
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